Baby Safety / Compounds / gamma-Valerolactone

Is gamma-Valerolactone safe for babies and kids?

Low risk for kids

(Babies-specific data is limited; this page draws from human adult context.) gamma-Valerolactone poses low risk to adults under normal use conditions.

What is gamma-valerolactone?

The IUPAC name is oxolan-2-one, 3-methyl-.

Also known as: oxolan-2-one, 3-methyl-, solvent, 4-Pentanolide, 4-Valerolactone.

IUPAC name
oxolan-2-one, 3-methyl-
CAS number
108-29-2
Molecular formula
C5H8O2
Molecular weight
100.12 g/mol
SMILES
CC1CCC(=O)O1
PubChem CID
7921

Risk for babies

Low risk

gamma-Valerolactone poses low risk to adults under normal use conditions.

Regulatory consensus

2 regulatory and scientific bodies have classified gamma-Valerolactone. The classifications differ — that's the data.

AgencyYearClassificationNotes
IFRA——IFRA standard
EU——EU approved

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter gamma-valerolactone

  • Perfume
  • Personal Care

Safer alternatives

Lower-risk approaches that achieve a similar outcome to gamma-Valerolactone:

  • Fragrance-free product formulations
    Trade-offs: Eliminates allergen risk entirely; consumer acceptance varies (some associate scent with cleanliness/efficacy); growing market segment; regulatory advantage in EU (no IFRA compliance needed).
    Relative cost: Lower (ingredient elimination)
  • Essential oil-free synthetic fragrance blends with established safety profiles
    Trade-offs: Allows scent without specific natural allergens; synthetic molecules can be individually safety-tested; some synthetics have their own sensitization profiles; cost comparable to natural blends.
    Relative cost: Lower (ingredient elimination)
  • Encapsulated fragrance technologies (reduced dermal contact)
    Trade-offs: Reduces dermal contact by 60-90% via polymer shell release mechanism; higher formulation cost; may alter scent perception (delayed release); shell material itself requires safety assessment.
    Relative cost: 1.2-2×
  • Naturally-derived isolates at IFRA-compliant concentrations
    Trade-offs: Alternative fragrance ingredient; individual safety profile should be assessed per IFRA standards; sensitization potential varies by compound; patch testing recommended for sensitive individuals.
    Relative cost: 2-5× conventional

Frequently asked questions

No FAQ entries generated.

See gamma-Valerolactone in the baby app

Look up products containing gamma-valerolactone, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. ATSDR Toxicological Profile — CAS 108-29-2 — reference

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →